Clinical and Translational Prevention of Lymphedema

Unlocking the Mysteries of Lymphatic
Malformations: Understanding Symptoms, Causes, and Effective Treatments

Michael Kelly, MD, PhD Executive Director, Lymphangiomatosis & Gorham’s Disease Alliance (LGDA)

May 14, 2025

Drug-repurposing in lymphedema research – using reverse
translation to identify tangible pharmacological approaches

Epameinondas Gousopoulos, MD, PhD Head, Researcher Lab

May 12, 2025

The Only Way to Treat Lymphedema is Through a Multidisciplinary Approach

Tim Decock, PT, ET, MT CEO, Decockliniek Belgium & Lymph House Antwerp

April 08, 2025

Better Research & Health Care with Patients &
Next-of-kin Collaboration

Margareta Haag & Mikaela Friedman, PhD Collaborators, Patient Advocacy

February 17, 2025

Finding a Drug to Treat Lymphedema: An Update

Stanley Rockson, MD Allan and Tina Neill Professor of Lymphatic Research and Medicine, Stanford University School of Medicine

January 26, 2025

GLP-1 Receptor Agonists are not Just for Weight Loss
Can They Help Prevent and Treat Lymphedema?

Joseph Dayan, MD Reconstructive Surgeon, Institute for Lymphatic Surgery and Innovation

December 10, 2024

Building a Comprehensive Lymphedema Program in a Rural Area

Stefanos Boukovalas, MD Reconstructive Surgeon, University of Tennessee Medical Center

November 20, 2024

Lymphedema vs. Lipedema: Differences in Diagnosis and Treatment

Jay Granzow, MD, MPH, FACS Director Surgeon, Granzow Lymphedema & Lipedima Center

October 23, 2024

Modern Concepts in Surgical Treatment and Prevention of Lymphedema

Joseph Dayan, MD Reconstructive Surgeon, Institute for Lymphatic Surgery and Innovation

October 01, 2024